Chr. Augustinus Fabrikker, an investment company with extensive interests in Danish business, invested €48m ($53m) in Abacus Medicine, a Danish pharmaceutical company. Flemming Wagner, CEO and founder of Abacus Medicine, says: “Abacus Medicine has delivered high growth year after year, and we have ambitions for even more. That is why we have been looking for the right, long-term partner to provide us with additional capital. We have found that now, and I look forward to the cooperation. Chr. Augustinus Fabrikker represents an invaluable experience that will strengthen us in our efforts to develop Abacus Medicine into a global company. ”